-
Rene Eyre Revisits Autobiographical Performance 'Say A Little Prayer' in London
-
London Museum Granted 24/7 License Ahead of November Opening
-
UAE's HCT Holds Record Graduation and Announces Major Training Expansion
-
Dana White Confirms Flight to Washington for Trump Meeting on Press Secretary Role
-
NASA Awards $10B Lunar Contract Framework to SpaceX, Blue Origin
-
Dengue Fever Expands Into High Himalayas as Climate Change Warms Nepal
-
Katy Perry Tells Fans Ex-Husband Russell Brand 'Should Be in Jail' During UK Concert
-
IoT Refrigerator Hacks Disrupt Blood Labs and Supermarkets Across Europe and US
-
South African election results renew debate over identity-based voting
-
Post-election pressures complicate US and Israeli decisions on Iran
-
South African voters report smoother local election but declining IEC trust
-
UN members approve talks on treaty protocol against environmental crime
-
Dolly Parton museum and Nashville hotel open after singer’s death
-
Family-run West Sussex beach café prepares for first winter season
-
George and Amal Clooney attend New York political-comedy reading
-
CT scans reveal health and burial clues from Egypt’s Braided Lady mummy
-
British buyers pay substantial premiums for period-home appearance
-
Oxford faces complaints over lecturer’s classroom attire
-
Thomas Markle released to house arrest after child-abuse-image charge
Featured
Last news
Acting US attorney general pursues Trump grievances at Justice Dept
US President Donald Trump fired Pam Bondi as attorney general last month, reportedly for failing to successfully prosecute several of his perceived political foes.
Spirit exit likely to lead to higher US airfares, experts say
The demise of ultra low-cost carrier Spirit Airlines is expected to add further upward pressure to US fares, according to experts.
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
The show broadcasts as sponsored programming with commercials by Synergy CHC Corp. (NASDAQ:SNYR), YY Group Holding Limited (NASDAQ:YYGH), DataVault AI (NASDAQ:DVLT), Medicus Pharma Ltd. (NASDAQ:MDCX), and IGC Pharma (NYSE American:IGC)
WHO chief due in Canaries to coordinate hantavirus ship evacuation
The World Health Organization's chief is due in the Spanish island of Tenerife on Saturday to help coordinate the evacuation of passengers hit by the hantavirus, Spanish ministry sources said.
Hantavirus scare revives Covid-era conspiracy theories
An outbreak of the deadly hantavirus on a Dutch-flagged cruise ship is reviving conspiracy theories about vaccines, alleged depopulation campaigns and miracle cures that flourished during the Covid pandemic.
Report revives speculation China Eastern crash was deliberate
A report into a fatal airline crash by an independent US government investigative agency has renewed speculation that one of China's biggest aviation disasters was deliberate.
French couple from virus-hit ship describe voyage as 'unlikely adventure'
Julia and Roland Seitre, a French couple aboard the cruise ship hit by a deadly hantavirus outbreak, said passengers remained calm, called their journey an "unlikely adventure", and urged against unnecessary drama.
WHO says hantavirus risk low as countries prep repatriation flights
The World Health Organization insisted Friday that the hantavirus outbreak posed a minimal risk to the general public, as countries prepared to repatriate passengers stuck on the cruise ship hit by a deadly outbreak.
What to know about Nigeria's court martial over 2025 coup plot
A court martial over last year's foiled coup plot in Nigeria is expected to get under way Friday, two weeks after the judges were sworn in.
'Blessed' Leo marks one year as pope with southern Italy visit
Pope Leo XIV said he felt "blessed" as he marked one year as leader of the Catholic Church on Friday with a visit to southern Italy, after weeks dominated by a clash with Washington.
Leo marks one-year anniversary with visit to southern Italy
Pope Leo XIV marks one year as leader of the Catholic Church Friday with a visit to southern Italy, celebrating the milestone with his flock after weeks dominated by a clash with Washington.
Indonesia volcanic eruption kills three hikers: officials
Three hikers, including two foreigners, died and 10 were missing after Mount Dukono on Indonesia's eastern Halmahera island erupted Friday, spewing an ash cloud about 10 kilometres (6.2 miles) into the air, a local police chief said.
Caged and fed 'cookies': Rescuing Armenia's captive bears
For years, Syrian brown bears Nairi, Aram and their cub Lola were trapped in a three-metre-wide cage in Armenia's capital Yerevan, living in their own faeces and fed with sweets.
Leo marks one year as pope in Pompeii, Naples
Pope Leo XIV marks one year as leader of the Catholic Church Friday with a visit to southern Italy, returning to his flock after weeks dominated by a clash with Washington.
IS-linked Australian women charged with keeping slave in Syria
Two Australian women "kept a female slave" after travelling to Syria in 2014 to support the Islamic State group, police said Friday after they were charged in Melbourne.
Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
VANCOUVER, BC / ACCESS Newswire / May 8, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc. ("Nucro-Technics"), a Toronto-based contract research organization collaborating with Onco on preclinical development, has commenced advanced bioanalytical work in support of the Company's ongoing non-GLP1 pharmacokinetic (PK) and biodistribution animal model study involving A83B4C63, the active pharmaceutical ingredient ("API") for Onco's exclusively-licensed PNKP Inhibitor Technology (the "Technology"). The initiation of this work represents a significant step forward in translating the Technology from early-stage discovery into a development-ready therapeutic candidate.
EU Regulators Say Charlotte's Web Hemp CBD Safety "Cannot Be Established" - So Why Is It Entering Medicare?
"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, and Patient Protections" stated Duane Boise CEO MMJ International Holdings.
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
HILLSIDE, NJ / ACCESS Newswire / May 8, 2026 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2026.
The Dixie Group 2026 Q1 Earnings Release and Conference Call
DALTON, GA / ACCESS Newswire / May 8, 2026 / You are invited to participate in a conference call with the management of THE DIXIE GROUP, INC (OTCQB:DXYN) regarding results for 2026 First Quarter Earnings Release on Monday, May 11, 2026, at 10:00 a.m. Eastern Time.
Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed
2026 revenue forecast raised: Zacks increases 2026 revenue estimate to $103.2 million, up from $98.6 million in its prior January 2026 reportEPS outlook upgraded: Zacks now expects Cosmos Health to cross into positive EPS territory in 2026$4.50 valuation reaffirmed: Updated report maintains valuation target, citing improving fundamentals and operational momentumLong-term growth trajectory maintained: Zacks continues to project revenue of approximately $130.8 million in 2027"Clear inflection point": Zacks highlights Cosmos Health's accelerating operational momentum and strategic evolution into a higher-margin healthcare platform with multiple growth vectors
Experts Warn GOP: Don't Side With Hospital Lobby Over Trump 340B Reforms
WASHINGTON, D.C. / ACCESS Newswire / May 8, 2026 / The Hospital Accountability Project convened a roundtable of leading health policy experts this week to examine abuse in the federal 340B Drug Pricing Program and the urgent need for reform.
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals
PHILADELPHIA, PA / ACCESS Newswire / May 8, 2026 / TruMerit, a global leader in healthcare workforce development and credential verification, today announced that it has issued its first verifiable digital credentials to healthcare professionals through a new partnership with Credivera, marking a major step forward in secure, portable credential verification for the global healthcare workforce.
Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
SAN FRANCISCO, CA / ACCESS Newswire / May 8, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update on the status of the Company's listing on The Nasdaq Stock Market ("Nasdaq"). On May 6, 2026, Jaguar received a decision letter from the Nasdaq Hearings Panel ("Panel") granting the Company's request for an extension to demonstrate compliance with the Nasdaq Listing Rules.
Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
CENTENNIAL, CO / ACCESS Newswire / May 8, 2026 / Nepra Foods Inc. (CSE:NPRA)(OTCQB:NPRFF) ("Nepra" or the "Company") announced today that it will be participating in the 16th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel in Los Angeles, CA May 18th and 19th, 2026. Nepra Foods has been invited to present at this year's event. Billy Hogan, CEO, Chadwick White, CVO, and Kim Mayo, Investor Relations, will be speaking on behalf of the Company.
Black Book Nurses Week Survey: Payer Delays Are Reaching the Bedside Before Hospital C-Suite Sees the Damage
Third report in Black Book's five-month Nurses Week research series warns that prior authorization, denials, formulary barriers, and opaque payer decisions are creating hidden nursing workload, delayed discharges, medication gaps, and patient-safety risk.
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
~ Chemical Control, Clinical Confidence: Rethinking Opioids ~
Judge Takes CMS HEMP-MARIJUANA CBD Program Under Advisement - As Evidence Mounts That Medicare May Be Moving Ahead of FDA Science
In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid Access Without FDA Approval.Duane Boise, CEO of MMJ International Holdings stated "By holding the motion under advisement rather than ruling immediately, the court signaled that the issue is both complex and consequential."
Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Exercise of Warrants and Issue of Equity
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 08
InterContinental Hotels Group PLC (the "Company")Purchase of own shares
30 passengers left hantavirus ship in Saint Helena: cruise operator
A total of 30 passengers left the hantavirus-stricken Hondius during its call at the remote British island of Saint Helena, the cruise ship's Dutch operator said Thursday.
US underlines 'strong' Vatican ties after Rubio meets pope
The US State Department underlined its "strong relationship" with the Vatican on Thursday after talks between top diplomat Marco Rubio and Pope Leo, weeks after Donald Trump's astonishing attack on the first US pontiff.
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
SAN DIEGO, CA / ACCESS Newswire / May 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today reported its financial results for the three months ended March 31, 2026.